Status:
COMPLETED
Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Photopill Medical Ltd
Conditions:
Ulcerative Colitis
Proctitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Low Level Light therapy (LLLT) has been used for tissue healing in many mucosal diseases that involve wounds, ulcers and inflammation, oral chemotherapy-induced mucositis in particular. Likewise IBD i...
Eligibility Criteria
Inclusion
- Diagnosed with Ulcerative Proctitis (Mayo grade 1/2)
Exclusion
- Symptomatic hemorrhoids
- Pregnant or lactating females
- Patients that have used any experimental treatment within 8 weeks prior to Day 0
- Patient that have used any biologics therapies or immunomodulation agents and/or steroids 4 weeks prior to Day 0
- Rectal therapy 2 weeks prior to Day 0
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01837615
Start Date
January 1 2013
End Date
June 1 2015
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center
Amsterdam, North Holland, Netherlands, 1105 AZ